Abstract Long coronavirus disease (Long COVID, post-acute sequelae of SARS-CoV-2 infection [PASC]) has emerged as a major chronic health challenge affecting multiple organ systems. Although pulmonary, cardiovascular, and neurologic manifestations […]
COVID-19–Associated Kidney Injury: Pathophysiology, Genomics, Clinical Progression, Therapeutic Strategies, and Long-Term Outcomes
A Comprehensive Scientific Review Abstract Since its emergence in 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been recognized not only as a respiratory pathogen but as a multisystem […]
COVID-19 and Edema
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has increasingly been recognized not merely as a viral pneumonic illness but as a diffuse endothelial and […]
Long COVID and the Kidney: Etiology, Genomic Susceptibility, Pathophysiology, and Clinical Management
John Murphy, M.D., M.P.H., D.P.H., President COVID-19 Long-haul Foundation A Comprehensive Review Table of Contents Abstract Introduction Figure 1: Schematic of systemic organ involvement in long COVID with emphasis on […]
COVID vaccine under new scrutiny after studies reveal possible health risks
Experts say studies don’t prove causation, but only show association By Melissa Rudy Fox News Two large studies have put a spotlight on potential health risks of the COVID vaccine — but some experts […]
Effect of positive end-expiratory pressure on acute kidney injury in patients with COVID-19
Poirot, Leo; Tchatat Wangueu, Lionel; Breteau, et. al. J Intensive Care BACKGROUND: Acute Kidney Injury (AKI) is common in patients admitted to the intensive care unit (ICU) for severe SARS-CoV-2 […]
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease
Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730 PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
🧠 COVID Long-Haul and Kidney Damage: What We Know After Five Years
Five years into the COVID-19 pandemic, long-haul symptoms continue to affect millions—and the kidneys are emerging as one of the most vulnerable organs in this prolonged aftermath. While much attention […]
🦠 Long COVID and Urinary Tract Infections (UTIs): 2025 Insights into Etiology, Symptoms, Progression, and Renal Complications
Emerging 2025 research reveals a compelling link between Long COVID and urinary tract infections (UTIs), with implications for kidney damage, bladder dysfunction, and chronic urinary symptoms. This article synthesizes findings […]